Literature DB >> 20800300

Revision of the ADA-classification of diabetes mellitus type 2 (DMT2): the importance of maturity onset diabetes (MOD), and senile diabetes (DS).

Marco Vacante1, Michele Malaguarnera, Massimo Motta.   

Abstract

The changing social and economic conditions and the increase of the life span induced a progressive increase of the general prevalence of DMT2, particularly in the elderly population of the highly evoluted countries. Up to now 18 genetic loci have been identified, each of them consisting of several single nucleotide polymorphisms (SNPs). The evidence that the DMT2 is regulated by a high number of genes, demonstrate the pathogenetic complexity of this disease. The onset of diabetes mellitus (DM) in medium age is a consequence of the breakdown of the glycemic homeostasis in correlation with the genetic factors, such as the variants of the TCF7L2, obesity, etc., and the environmental factors, such as the life-style, the evolution of chronic-degenerative diseases, etc. In case of DM that onsets in old age we have to add the deterioration of the anti-aging defense mechanisms, characterized by the antagonistic action of the genes of longevity and aging. One can observe several clinical and therapeutic differences; therefore, the authors of this review propose the reinsertion of three forms into the DMT2 correlated with the age of onset and with the actual age of the subjects: the maturity onset diabetes (MOD), the maturity onset diabetes in elderly (MODE), and the senile diabetes (DS).
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20800300     DOI: 10.1016/j.archger.2010.06.017

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  6 in total

Review 1.  Impact of glucose level on morbidity and mortality in elderly with diabetes and pre-diabetes.

Authors:  Orit Twito; Meir Frankel; Dan Nabriski
Journal:  World J Diabetes       Date:  2015-03-15

2.  Association of New-Onset Diabetes Mellitus in Older People and Mortality in Taiwan: A 10-Year Nationwide Population-Based Study.

Authors:  M-J Chi; C-K Liang; W-J Lee; L-N Peng; M-Y Chou; L-K Chen
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

Review 3.  Optimal therapy of type 2 diabetes: a controversial challenge.

Authors:  Angela Dardano; Giuseppe Penno; Stefano Del Prato; Roberto Miccoli
Journal:  Aging (Albany NY)       Date:  2014-03       Impact factor: 5.682

4.  Comparison of Age of Onset and Frequency of Diabetic Complications in the Very Elderly Patients with Type 2 Diabetes.

Authors:  Bong Ki Lee; Sang Wook Kim; Daehee Choi; Eun Hee Cho
Journal:  Endocrinol Metab (Seoul)       Date:  2016-08-26

5.  Insulin Glargine and Acarbose in the treatment of elderly patients with diabetes.

Authors:  Jing Li; Jinzhi Ji; Fuyan Liu; Lingling Wang
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

6.  Clinical experience with exenatide in obese North Indian patients with type 2 diabetes mellitus.

Authors:  Tarunika Bawa; Vibha Dhingra; Nidhi Malhotra; Jasjeet S Wasir; Ambrish Mithal
Journal:  Indian J Endocrinol Metab       Date:  2013-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.